Detail of the session

Type :
FOCUS SESSION 6

Date :
Friday 26^th April 2019

Schedule :
14h00 - 15h30

Session Title :

FS06 - Focus Session 6 – Advances and Latest Insights in Non Biologic Systemic Therapeutic Agents in Psoriasis and Atopic Dermatitis

O036
14h00 - 14h15

Fumarates / Vitamin A Derivatives
Peter VAN DE KERKHOF - Netherlands

O037
14h15 - 14h30

CsA / MMF /Azathioprine
César GONZALEZ - Colombia

O038
14h30 - 14h45

MTX
Rolland GYULAI - Hungary

O039
14h45 - 15h00

Small molecules, apremilast and beyond.
Richard LANGLEY - Canada

P011
15h00 - 15h05

UPADACITINIB IMPROVED PATIENT-REPORTED PRURITUS IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM A PHASE 2B RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Chih-Ho HONG - Canada

P012
15h05 - 15h10

DRUG SURVIVAL OF FUMARIC ACID ESTERS (FAE) FOR MODERATE-TO-SEVERE PSORIASIS IN A GERMAN PSORIASIS REGISTRY: PSOBEST
Christina SORBE - Germany

P013
15h10 - 15h15

INTERIM ANALYSIS OF SKILL NON-INTERVENTIONAL STUDY: DIMETHYLFUMARATE IN LONG-TERM TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN ROUTINE PRACTICE – CHARACTERISATION OF PATIENT POPULATION IN COMPARISON WITH PSOBEST AND PSOHEALTH
Matthias AUGUSTIN - Germany